{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:05:58Z","timestamp":1778774758497,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jid.2015.10.050","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T08:47:40Z","timestamp":1453279660000},"page":"352-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015"],"prefix":"10.1016","volume":"136","author":[{"given":"Jouni","family":"Uitto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Bruckner-Tuderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Christiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Has","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"South","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Kopelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Clare","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2015.10.050_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.celrep.2014.04.036","article-title":"LIF mediates proinvasive activation of stromal fibroblasts in cancer","volume":"7","author":"Albrengues","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2015.10.050_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.0022-202X.2004.23418.x","article-title":"Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"123","author":"Arbiser","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","article-title":"Namy O Sense from nonsense: therapies for premature stop codon diseases","volume":"18","author":"Bidou","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jid.2015.10.050_bib4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/jid.2015.129","article-title":"A drosophila model of epidermolysis bullosa simplex","volume":"135","author":"Bohnekamp","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/jid.2010.75","article-title":"Animal models of epidermolysis bullosa: update 2010","volume":"130","author":"Bruckner-Tuderman","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/jid.2013.127","article-title":"Progress in epidermolysis bullosa research: Summary of DEBRA International Research Conference 2012","volume":"133","author":"Bruckner-Tuderman","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jid.2015.10.050_bib8","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/mt.2014.187","article-title":"Long-term skin regeneration from a gene-targeted human epidermal stem cell clone","volume":"22","author":"Duarte","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2015.10.050_bib9","article-title":"Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial","author":"El-Darouti","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2015.10.050_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006","volume":"60","author":"Fine","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2015.10.050_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jpeds.2015.05.051","article-title":"Reduced toxicity conditioning and allogeneic hematopoietic progenitor cell transplantation for recessive dystrophic epidermolysis bullosa","volume":"167","author":"Geyer","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jid.2015.10.050_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2009.09118.x","article-title":"Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy","volume":"161","author":"Gostynski","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaad.2013.08.052","article-title":"Successful therapeutic transplantation of revertant skin in epidermolysis bullosa","volume":"70","author":"Gostynski","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/jid.2014.466","article-title":"A new mouse model of junctional epidermolysis bullosa: the LAMB3 628G>A knockin mouse","volume":"135","author":"Hammersen","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib16","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","article-title":"Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa","volume":"112","author":"Heinonen","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jid.2015.10.050_bib17","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/ncomms6932","article-title":"Innate sensing of microbial products promotes wound-induced skin cancer","volume":"6","author":"Hoste","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2015.10.050_bib18","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1038\/jid.2015.291","article-title":"Intravenously administered recombinant human type VII collagen derived from Chinese hamster ovary cells reverses the disease phenotype in recessive dystrophic epidermolysis bullosa mice","volume":"135","author":"Hou","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/jid.2014.443","article-title":"Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice","volume":"135","author":"Hurskainen","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib20","first-page":"S7","article-title":"Expression and regulation of cathelicidin in keratinocytes from patients with epidermolysis bullosa","volume":"132","author":"H\u00fcttner","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib21","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","article-title":"Transplanted bone marrow-derived circulating PDGFRalpha+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft","volume":"194","author":"Iinuma","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2015.10.050_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81894-2","article-title":"Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion","volume":"88","author":"Jonkman","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jid.2015.10.050_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.matbio.2010.07.002","article-title":"Zebrafish type XVII collagen: gene structures, expression profiles, and morpholino \u201cknock-down\u201d phenotypes","volume":"29","author":"Kim","year":"2010","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2015.10.050_bib24","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/jid.2014.118","article-title":"Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa","volume":"134","author":"Kiritsi","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/ijms16011179","article-title":"Trans-splicing improvement by the combined application of antisense strategies","volume":"16","author":"Koller","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2015.10.050_bib26","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin inegrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"Kuehl","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2015.10.050_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2013.17","article-title":"Global remodeling of cellular microenvironment due to loss of collagen VII","author":"K\u00fcttner","year":"2013","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jid.2015.10.050_bib28","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/jid.2014.182","article-title":"Zebrafish as a model system to study skin biology and pathology","volume":"134","author":"Li","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3727\/096368913X663569","article-title":"Human cord blood-derived unrestricted somatic stem cells promote wound\u00a0healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa","volume":"23","author":"Liao","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jid.2015.10.050_bib30","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/stem.1966","article-title":"Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa","volume":"33","author":"Liao","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.jid.2015.10.050_bib31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jid.2015.10.050_bib32","article-title":"Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa - best clinical practice guidelines","author":"Mellerio","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdermsci.2013.03.011","article-title":"Calcipotriol modulates IL-22 receptor expression and keratinocyte proliferation in IL-22-induced epidermal hyperplasia","volume":"71","author":"Moniaga","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2015.10.050_bib34","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jid.2011.85","article-title":"HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: Possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa","volume":"131","author":"Nagy","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib35","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2015.10.050_bib36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystr\u00f6m","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jid.2015.10.050_bib37","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI68127","article-title":"Bruckner-Tuderman L Collagen VII plays a dual role in wound healing","volume":"123","author":"Nystr\u00f6m","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2015.10.050_bib38","first-page":"167","article-title":"Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy","volume":"14","author":"Pasmooij","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.jid.2015.10.050_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/scrt511","article-title":"Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa","volume":"5","author":"Perdoni","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jid.2015.10.050_bib40","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib42","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/sj.jid.5700878","article-title":"Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression","volume":"127","author":"Pourreyron","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","article-title":"Injection of recombinant human\u00a0type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa","volume":"17","author":"Remington","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2015.10.050_bib44","doi-asserted-by":"crossref","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","article-title":"Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Sebastiano","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2015.10.050_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.12885","article-title":"Burden of itch in epidermolysis bullosa","volume":"171","author":"Snauwaert","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib46","doi-asserted-by":"crossref","first-page":"e1004068","DOI":"10.1371\/journal.pgen.1004068","article-title":"Molecular identification of collagen17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice","volume":"10","author":"Sproule","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jid.2015.10.050_bib47","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFR{alpha}-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jid.2015.10.050_bib48","first-page":"A534","article-title":"Hematopoietic and mesenchymal cell transplantation after myeloablative and non-myeloablative conditioning for recessive dystrophic and junctional epidermolysis bullosa (RDEB, JEB)","volume":"132","author":"Tolar","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib49","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/jid.2013.523","article-title":"Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa","volume":"134","author":"Tolar","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-767-5_15","article-title":"Antisense-mediated exon skipping to reframe transcripts","volume":"867","author":"Turczynski","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jid.2015.10.050_bib51","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/jid.2010.90","article-title":"Progress in epidermolysis bullosa research: toward treatment and cure","volume":"130","author":"Uitto","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib52","doi-asserted-by":"crossref","first-page":"264ra164","DOI":"10.1126\/scitranslmed.3009342","article-title":"Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa","volume":"6","author":"Umegaki-Arao","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2015.10.050_bib53","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","article-title":"A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa","volume":"69","author":"Venugopal","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2015.10.050_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1750-1172-8-69","article-title":"Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study","volume":"8","author":"Wally","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2015.10.050_bib56","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1073\/pnas.1114669108","article-title":"Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2015.10.050_bib57","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/mt.2013.87","article-title":"Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure","volume":"21","author":"Wang","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2015.10.050_bib58","doi-asserted-by":"crossref","first-page":"264ra165","DOI":"10.1126\/scitranslmed.3010083","article-title":"Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Wenzel","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2015.10.050_bib59","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI71919","article-title":"Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle","volume":"124","author":"Winter","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2015.10.050_bib60","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2015.10.050_bib61","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:43:51Z","timestamp":1654130631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0022202X15000512"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2015.10.050","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2015.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}